The Cineworld share price has turned a corner

Rupert Hargreaves explains why he thinks the outlook for the Cineworld share price is improving as theatregoers return to splash the cash.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I think the Cineworld (LSE: CINE) share price has turned a corner. I do not say that lightly.

For the past few months, I have been quite critical of the business. Its looming debt pile is concerning, and it is still not clear if consumers will return to theatres in large enough numbers to drive profit growth. 

So, if the company is still facing significant challenges, why have I changed my opinion on the business in the space of a week?

Turning a corner

Over the past few days, the sales figures for the latest James Bond instalment, No Time To Die, have been rolling in. The film smashed box office records in the UK, taking £25m in just three days. Immediately after these figures were released, the Cineworld share price jumped. 

The film took a more muted $56m from 4,407 theatres in the United States and Canada, but it has generally been well received around the world.

These figures suggest to me that Cineworld has received a cash infusion from the film, which it desperately needed. Not only that, but the numbers show that the cinemagoers are cautiously returning. 

I think this is important for two reasons.

First, it will show film producers that the market for straight-to-streaming films has limited scope. It worked during the pandemic. However, the success of No Time To Die shows there is still a market for blockbuster releases. This should encourage production houses to move more releases back to theatres. 

Secondly, the film’s success should prove to Cineworld’s creditors that the company is still worth backing. This will be vital when the group comes to renegotiating its obligations. 

I believe both of these factors removed some of the heat from the Cineworld share price. The blockbuster success should show creditors the business is still worth backing. Meanwhile, more film releases should encourage more customers back into theatres. The numbers also show that consumers are willing to return to cinemas. 

The Cineworld share price outlook

Having said all of the above, there is no denying that Cineworld faces an uphill struggle from here. Its debt mountain means the business has virtually no room to manoeuvre. Further coronavirus restrictions could also setback the recovery significantly. 

However, it is now clear to me that the company is heading in the right direction. Further, if management’s plans to raise capital through a US listing or spinoff come to fruition, the group will be able to greatly reduce its debt pile and remove this substantial threat hanging over the Cineworld share price. 

Those are the reasons why I would acquire a small speculative position in the corporation for my portfolio today. Due to the risks associated with the business, this company might not be suitable for all investors, as it could be sometime before the group makes a full recovery. In the meantime, there is plenty that could go wrong. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Down 53% in a year! I reckon this oversold FTSE 100 stock is now ripe for a comeback

This FTSE 100 stock has fallen out of fashion with investors, but Harvey Jones reckons the sell-off has gone too…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

How much second income would I get if I put £10k into dirt cheap Centrica shares?

Centric shares have been looking incredibly cheap despite rocketing in recent years. Harvey Jones wonders whether this is an opportunity…

Read more »

artificial intelligence investing algorithms
Investing Articles

If I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have now

Harvey Jones is kicking himself for failing to buy AstraZeneca shares before the took off. Is there still a decent…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How I’d find shares to buy for an early retirement

Christopher Ruane explains some of the factors he considers when looking for shares to buy that could potentially help him…

Read more »

Investing Articles

Why I’d snap up bargain UK shares to try and build wealth

Christopher Ruane explains how he hopes to find high-quality UK shares selling at attractive prices, to help him build wealth…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how I’d target a £2k annual second income from a £20k Stocks & Shares ISA

Our writer explains how he’d try to earn thousands of pounds annually in dividends by investing a £20k ISA in…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

The £20k Stocks and Shares ISA might be one of the better things about living in the UK

The £20k Stocks and Shares ISA doesn't have many equivalents in other countries. Here's why these accounts can help UK…

Read more »